Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 7028289, 9 pages
http://dx.doi.org/10.1155/2016/7028289
Research Article

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

1Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
3Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China

Received 18 April 2016; Revised 7 August 2016; Accepted 11 August 2016

Academic Editor: Francesca Borrelli

Copyright © 2016 Song Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Wolfgang, J. M. Herman, D. A. Laheru et al., “Recent progress in pancreatic cancer,” CA: A Cancer Journal for Clinicians, vol. 63, no. 5, pp. 318–348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Vincent, J. Herman, R. Schulick, R. H. Hruban, and M. Goggins, “Pancreatic cancer,” The Lancet, vol. 378, no. 9791, pp. 607–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Gutt, S. L. Liauw, and R. R. Weichselbaum, “The role of radiotherapy in locally advanced pancreatic carcinoma,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 8, pp. 437–447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. H. Shen, L. M. Liu, X. Y. Zhu et al., “A clinical trial on the effect of Qingyi Huaji herbal decoction combined with transcatheter arterial chemotherapy and radiotherapy for inoperable pancreatic cancer,” Journal of Traditional Chinese Medicine, vol. 51, no. 12, pp. 1093–1096, 2010. View at Google Scholar
  6. Y. L. Xu, S. Gao, L. M. Liu et al., “Clinical analysis on 20 cases of long term survival patients with advanced pancreatic cancer,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 29, no. 8, pp. 2679–2681, 2014. View at Google Scholar
  7. I. Chambers, D. Colby, M. Robertson et al., “Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells,” Cell, vol. 113, no. 5, pp. 643–655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. Hoei-Hansen, “Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men,” Cancer Treatment Reviews, vol. 34, no. 4, pp. 348–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. U. I. Ezeh, P. J. Turek, R. A. Reijo Pera, and A. T. Clark, “Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma,” Cancer, vol. 104, no. 10, pp. 2255–2265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Miyoshi, H. Ishii, K.-I. Nagai et al., “Defined factors induce reprogramming of gastrointestinal cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 40–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Bussolati, S. Bruno, C. Grange, U. Ferrando, and G. Camussi, “Identification of a tumor-initiating stem cell population in human renal carcinomas,” The FASEB Journal, vol. 22, no. 10, pp. 3696–3705, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Gao, P. Wang, Y. Hua et al., “ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer,” Oncotarget, vol. 7, no. 2, pp. 1608–1618, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Chen, L.-Y. Chen, P. Wang, H.-Y. Dai, S. Gao, and K. Wang, “Tumor microenvironment varies under different TCM ZHENG models and correlates with treatment response to herbal medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 635702, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Wang, Z. Chen, Z.-Q. Meng et al., “Ski acts as therapeutic target of Qingyihuaji formula in the treatment of SW1990 pancreatic cancer,” Integrative Cancer Therapies, vol. 9, no. 1, pp. 50–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Zhang, P. Wang, H. Ouyang et al., “Targeting cancer-related inflammation: Chinese Herbal Medicine Inhibits Epithelial-to-Mesenchymal Transition in Pancreatic Cancer,” PLoS ONE, vol. 8, no. 7, article e70334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Li, K. Xie, R. Wolff, and J. L. Abbruzzese, “Pancreatic cancer,” The Lancet, vol. 363, no. 9414, pp. 1049–1057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Ben-Porath, M. W. Thomson, V. J. Carey et al., “An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors,” Nature Genetics, vol. 40, no. 5, pp. 499–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Feske, “Calcium signalling in lymphocyte activation and disease,” Nature Reviews Immunology, vol. 7, no. 9, pp. 690–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. Jeter, B. Liu, X. Liu et al., “NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation,” Oncogene, vol. 30, no. 36, pp. 3833–3845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-H. Yin, W.-D. Shi, X.-Y. Zhu, Z. Chen, and L.-M. Liu, “Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF,” Integrative Cancer Therapies, vol. 11, no. 1, pp. 37–47, 2012. View at Publisher · View at Google Scholar · View at Scopus